[HTML][HTML] Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra …
M Pallebage-Gamarallage, S Foxley, RAL Menke… - BMC neuroscience, 2018 - Springer
Background Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, S Foxley… - BMC …, 2018 - research.sahmri.org.au
Background: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, KL Miller, O Ansorge… - BMC …, 2018 - hero.epa.gov
Background: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, S Foxley, R Menke… - BMC …, 2018 - ora.ox.ac.uk
Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous
neurodegenerative disorder, in which therapy is hindered by the rapid progression of …
neurodegenerative disorder, in which therapy is hindered by the rapid progression of …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, S Foxley… - BMC …, 2018 - europepmc.org
Background Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, S Foxley, RAL Menke… - BMC …, 2018 - go.gale.com
Background Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
[HTML][HTML] Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high …
M Pallebage-Gamarallage… - BMC …, 2018 - bmcneurosci.biomedcentral.com
Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically heterogeneous
neurodegenerative disorder, in which therapy is hindered by the rapid progression of …
neurodegenerative disorder, in which therapy is hindered by the rapid progression of …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, S Foxley, RAL Menke… - 2018 - digital.library.adelaide.edu.au
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, S Foxley… - BMC …, 2018 - psycnet.apa.org
Background: Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field …
M Pallebage-Gamarallage, S Foxley… - BMC …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Amyotrophic lateral sclerosis (ALS) is a clinically and histopathologically
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …
heterogeneous neurodegenerative disorder, in which therapy is hindered by the rapid …